World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 22 April 2013
Main ID:  NCT00392756
Date of registration: 25/10/2006
Primary sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Public title: Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
Scientific title: Role of Gonadotropin Pulsations in the Reversal of Hypogonadotropic Hypogonadism
Date of first enrolment: April 1989
Target sample size: 800
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00392756
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Countries of recruitment
United States
Contacts
Name:   Ravikumar Balasumbramanian, MD, PhD
Address: 
Telephone: 617-726-8432
Email: RBALASUBRAMANIAN@PARTNERS.ORG
Affiliation: 
Name:   Ravikumar Balasubramanian, MD, PhD
Address: 
Telephone: 617-726-8432
Email: RBALASUBRAMANIAN@PARTNERS.ORG
Affiliation: 
Name:   William F Crowley, Jr., MD
Address: 
Telephone:
Email:
Affiliation:  Massachusetts General Hospital
Key inclusion & exclusion criteria

Eligibility

Ages Eligible for Study:

- Adolescent boys (16-17yrs)

- Adults (18 years and older)

- Genders Eligible for Study:

- Male and Female

- Accepts Healthy Volunteers:

- No

Criteria

Inclusion Criteria:

- adolescent boys (age 16-17 years) and adult male individuals (age 18 years and older)
with a single serum sample demonstrating low testosterone in association with low or
inappropriately normal gonadotropin levels

- suitable male and adult female hypogonadotropic hypogonadal subjects

Exclusion Criteria:

- no specific exclusion criteria



Age minimum: 16 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
GnRH Deficiency
Hypogonadotropic Hypogonadism
Kallmann Syndrome
Intervention(s)
Drug: gonadotropin releasing hormone (GnRH)
Primary Outcome(s)
endogenous LH secretion pattern [Time Frame: 8 to 24 hours]
Secondary Outcome(s)
sperm count [Time Frame: up to 2 years]
testicular volume [Time Frame: up to 2 years]
Secondary ID(s)
5U54 HD028138
U54HD028138-024
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history